A Study to Evaluate the Cardiac Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Malignant Tumor
Clinical trial NCT05089461 · SUSPENDED
Trial details
- NCT number
- NCT05089461
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- SUSPENDED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-07
- Primary completion
- 2022-06-20
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.